Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Charlie Hospital Semarang Tbk.
RSCH
Sector: Healthcare
Industry: Healthcare Providers
Sub Sector: Healthcare Equipment & Providers
Sub Industry: Healthcare Providers
Live quote
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
-8
ROE
-16,65%
ROA
-10,49%
Book Value
45
Net Income
-10,03 M
Total Sales
32,73 M
Total Assets
191,23 M
DER
0.59x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
13,33%
PT. WAHYU AGUNG 🔗
79,43%
Corporate · Lokal
PT INVESTASI HARMONI SEJAHTERA 🔗
2,58%
Corporate · Lokal
PT KONSULTAMA SUKSES INDONESIA 🔗
2,54%
Corporate · Lokal
THEO CHANDRA HUTOMO 🔗
1,10%
Individual · Lokal
BENNY ANDREWIJAYA 🔗
1,02%
Individual · Lokal
Tentang Perusahaan
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Produk & Lini Bisnis
The Company is engaged in the activities of private hospitals. The Company's hospital is classified as a type D hospital,
Dewan Direksi
J
Junianto
President Director
SM
Sri Mulyaningsih
Director
Dewan Komisaris
WF
Wahyu Fitrianingsih
President Commissioner
RO
Roy Octavian
Independent Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
 %
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
114jt 86jt 57jt 29jt 0 Sales 2025Q2: Rp 27.662.390 Net Income 2025Q2: Rp -10.946.278 2025Q2 Sales 2025Q3: Rp 46.582.547 Net Income 2025Q3: Rp -14.896.781 2025Q3 Sales 2025Q4: Rp 114.396.662 Net Income 2025Q4: Rp -16.420.241 2025Q4 Sales 2026Q1: Rp 15.420.180 Net Income 2026Q1: Rp -4.146.405 2026Q1 Sales 2026Q2: Rp 32.727.440 Net Income 2026Q2: Rp -10.028.465 2026Q2
2025 Q2
EPS -8
ROE -16,10%
2025 Q3
EPS -8
ROE -15,04%
2025 Q4
EPS -6
ROE -12,58%
2026 Q1
EPS -6
ROE -13,12%
2026 Q2
EPS -8
ROE -16,65%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 32,73 M -10,03 M 191,23 M 120,49 M -8 -16,65% 0.59x
2026 Q1 15,42 M -4,15 M 198,65 M 126,37 M -6 -13,12% 0.57x
2025 Q4 114,40 M -16,42 M 202,55 M 130,52 M -6 -12,58% 0.55x
2025 Q3 46,58 M -14,90 M 276,94 M 132,06 M -8 -15,04% 1.10x
2025 Q2 27,66 M -10,95 M 283,77 M 136,01 M -8 -16,10% 1.09x
Trend Harga Penutupan & Book Value — hover titik untuk detail
Close Price Book Value
482 368 254 140 26 Book Value 2025Q2: Rp 51 Close 2025Q2: Rp 442 2025Q2 Book Value 2025Q3: Rp 50 Close 2025Q3: Rp 366 2025Q3 Book Value 2025Q4: Rp 49 Close 2025Q4: Rp 410 2025Q4 Book Value 2026Q1: Rp 48 Close 2026Q1: Rp 300 2026Q1 Book Value 2026Q2: Rp 45 Close 2026Q2: Rp 262 2026Q2
2025 Q2
Close 442
BV 51
ROA -7,71%
2025 Q3
Close 366
BV 50
ROA -7,17%
2025 Q4
Close 410
BV 49
ROA -8,11%
2026 Q1
Close 300
BV 48
ROA -8,35%
2026 Q2
Close 262
BV 45
ROA -10,49%
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 262 45 -10,49%
2026 1 300 48 -8,35%
2025 4 410 49 -8,11%
2025 3 366 50 -7,17%
2025 2 442 51 -7,71%
Data diperbarui pada: 2026-05-12 11:49:06